Home About ATSDR Press Room A-Z Index Glossary Employment Training Contact Us CDC  
ATSDR/DHHS Agency for Toxic Substances and Disease Registry Agency for Toxic Substances and Disease Registry Department of Health and Human Services ATSDR en Español

Search:

Section Contents
 
Learning Objectives
Introduction
Absorption
Excretion
Accumulation
Half-Life
Key Points
Progress Check
 
Case Contents
 
Table of Contents
Cover Page
How to Use This Course
Initial Check
Cadmium
Where Found
Exposure Pathways
Safety Standards
Who is at Risk
Pathogenic Changes
Acute Effects
Chronic Effects
Risk Factors
Clinical Assessment
Laboratory Evaluation
Treatment
Patient Instructions
More Information
Posttest
Literature Cited
 
Case Studies (CSEM)
 
CSEM Home
Continuing Education
Online Registration
 
ATSDR Resources
 
Case Studies (CSEM)
Exposure Pathways
GATHER (GIS)
Health Assessments
Health Statements
Interaction Profiles
Interactive Learning
Managing Incidents
Medical Guidelines
Minimal Risk Levels
Priority List
ToxFAQs™
ToxFAQs™ CABS
Toxicological Profiles
Toxicology Curriculum
 
External Resources
 
CDC
eLCOSH
EPA
Healthfinder®
Medline Plus
NCEH
NIEHS
NIOSH
OSHA
 

Agency for Toxic Substances and Disease Registry
Case Studies in Environmental Medicine (CSEM) 

Cadmium Toxicity
What Is the Biological Fate of Cadmium in the Body?


Learning Objectives

Upon completion of this section, you will be able to

  • describe the biologic fate of cadmium in the body.

Introduction


This section will discuss

  • how cadmium is taken into the body,
  • its absorption,
  • how it distributes throughout the body, and
  • why it accumulates in the human body due to its metabolism and excretion

How Cadmium Is Absorbed

The principal factor determining how much cadmium is absorbed is the route of exposure.  Once exposed, how much cadmium is absorbed depends on many factors:

  • age,
  • gender,
  • smoking, and
  • nutritional status.

As a cumulative toxin, cadmium body burden increases with age. Women have been shown to have higher blood levels of cadmium than men. Typically women, with lower iron status, are believed to be at risk for greater absorption of cadmium after oral exposure (Olsson et al. 2002).

Inhalation

Once in the lungs, from 10% to 50% of an inhaled dose is absorbed, depending on particle size, solubility of the specific cadmium compound inhaled, and duration of exposure (Jarup 2002). Absorption is least for large (greater than 10 micrometers [µm]) and water-insoluble particles, and greatest for particles that are small (less than 0.1 µm) and water soluble. A high proportion of cadmium in cigarette smoke is absorbed because the cadmium particles found in that type of smoke are very small (ATSDR 1999).

Ingestion

Most orally ingested cadmium passes through the gastrointestinal tract unchanged as normal individuals absorb only about 6% of ingested cadmium, but up to 9% may be absorbed in those with iron deficiency (ATSDR 1999). Also, cadmium in water is more easily absorbed than cadmium in food (5% in water versus 2.5% in food) (IRIS 2006). The presence of elevated zinc or chromium in the diet decreases cadmium uptake.

Dermal

Absorption through the skin is not a significant route of cadmium entry; only about 0.5% of cadmium is absorbed by the skin (ATSDR 1999).


Excretion of Cadmium

Absorbed cadmium is eliminated from the body primarily in urine. The rate of excretion is low, probably because cadmium remains tightly bound to metallothionein, MTN, which is almost completely reabsorbed in the renal tubules.

Because excretion is slow, cadmium accumulation in the body can be significant. Cadmium concentration in blood reflects recent exposure; urinary cadmium concentration more closely reflects total body burden. However, when renal damage from cadmium exposure occurs, the excretion rate increases sharply, and urinary cadmium levels no longer reflect body burden.


Accumulation of Cadmium

The total cadmium body burden at birth is non-detectable (CDC 2005). It gradually increases with age to about 9.5 mg to 50 mg (ATSDR 1999). The kidneys and liver together contain about 50% of the body’s accumulation of cadmium (HSDB 2006).


Cadmium Half-Life

The biologic half-life of cadmium in the kidney is estimated to be between 6 to 38 years; the half life of cadmium in the liver is between 4 and 19 years (ATSDR 1999). These long half-lives reflect the fact that humans do not have effective pathways for cadmium elimination. Cadmium has no known biologic function in humans. Bioaccumulation appears to be a by-product of increasing industrialization. Any excessive accumulation in the body should be regarded as potentially toxic.


Key Points

  • Cadmium has no known beneficial function in the human body.
  • Cadmium is a cumulative toxin.
  • Cadmium is transported in the blood bound to metallothionein.
  • The greatest cadmium concentrations are found in the kidneys and the liver.
  • Urinary cadmium excretion is slow; however, it constitutes the major mechanism of elimination.
  • Due to slow excretion, cadmium accumulates in the body over a lifetime and its biologic half life may be up to 38 years.

Progress Check

8. Once an individual is exposed, which of the following factors influence the amount of cadmium absorbed by the body?

A. Age.
B. Gender of the exposed individual.
C. Lower iron status.
D. All of the above.

Answer:

To review relevant content, see How Cadmium is Absorbed in this section.


Previous Section

Next Section

Revised 2008-05-12.